Race-Conscious Learning and Sociocultural Competence in an Academic Surgery Program: Diversity, Equity, and All-Inclusion Program.

Autor: Chhabra K; New York Medical College, Surgery, Valhalla, New York., Rajdeo H; New York Medical College, Surgery, Valhalla, New York., McGuirk M; New York Medical College, Surgery, Valhalla, New York., John D; New York Medical College, Surgery, Valhalla, New York., Castaldi M; New York Medical College, Surgery, Valhalla, New York. Electronic address: maria_castaldi@nymc.edu.

Publikováno v: The Journal of surgical research [J Surg Res] 2024 Sep; Vol. 301, pp. 88-94. Date of Electronic Publication: 2024 Jun 24.

VCP activator reverses nuclear proteostasis defects and enhances TDP-43 aggregate clearance in multisystem proteinopathy models.

Autor: Phan JM, Creekmore BC, Nguyen AT, Bershadskaya DD, Darwich NF, Mann CN, Lee EB

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 May 23; Vol. 134 (14). Date of Electronic Publication: 2024 May 23.

Investigating Liquid-Liquid Phase Separation in Virus-Generated Inclusion Bodies Using Fluorescence Recovery After Photobleaching of Fluorescently Labeled Host Proteins.

Autor: Asuelime-Smith MBT; The Department of Molecular, Cell, and Developmental Biology, University of California Santa Barbara, Santa Barbara, CA, USA., Ma DZ; Molecular, Cellular, and Developmental Biology, University of California Santa Barbara, Santa Barbara, CA, USA. zachma@ucsb.edu.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2808, pp. 129-140.

The predominance of "astrocytic" intranuclear inclusions in neuronal intranuclear inclusion disease manifesting encephalopathy-like symptoms: A case series with brain biopsy.

Autor: Ishizawa K; Department of Pathology, Saitama Medical University, Saitama, Japan.; Department of Neurology, Saitama Medical University, Saitama, Japan.; Department of Laboratory Medicine, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan., Komori T; Department of Laboratory Medicine, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan., Homma T; Department of Laboratory Medicine, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.; Department of Diagnostic Pathology, Saitama Medical University International Medical Center, Saitama, Japan., Sone J; Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Aichi, Japan., Nakata Y; Department of Neuroradiology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan., Nakazato Y; Department of Neurology, Saitama Medical University, Saitama, Japan., Takahashi K; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan., Yamamoto T; Department of Neurology, Saitama Medical University, Saitama, Japan., Sasaki A; Department of Pathology, Saitama Medical University, Saitama, Japan.

Publikováno v: Neuropathology : official journal of the Japanese Society of Neuropathology [Neuropathology] 2024 Oct; Vol. 44 (5), pp. 351-365. Date of Electronic Publication: 2024 Mar 13.

Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions.

Autor: Lam I; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Ndayisaba A; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Lewis AJ; École Polytechnique Fédérale de Lausanne and University of Lausanne, Lausanne, Switzerland., Fu Y; The University of Sydney Brain and Mind Centre and Faculty of Medicine and Health School of Medical Science, Sydney, NSW, Australia., Sagredo GT; The University of Sydney Brain and Mind Centre and Faculty of Medicine and Health School of Medical Science, Sydney, NSW, Australia., Kuzkina A; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Zaccagnini L; Dementia Research Institute, University College London, London, UK., Celikag M; Dementia Research Institute, University College London, London, UK., Sandoe J; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Sanz RL; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Vahdatshoar A; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Martin TD; Harvard Medical School, Boston, MA, USA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Morshed N; Harvard Medical School, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA; Boston Children's Hospital, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ichihashi T; Nikon Corporation, Tokyo, Japan., Tripathi A; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Ramalingam N; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Oettgen-Suazo C; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Bartels T; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Boussouf M; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Schäbinger M; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Hallacli E; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Jiang X; Yumanity Therapeutics, Cambridge, MA, USA., Verma A; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Tea C; University of California, San Diego, San Diego, CA, USA., Wang Z; University of California, San Diego, San Diego, CA, USA., Hakozaki H; University of California, San Diego, San Diego, CA, USA., Yu X; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Hyles K; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Park C; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Wang X; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Theunissen TW; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Wang H; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Jaenisch R; Whitehead Institute for Biomedical Research, Cambridge, MA, USA., Lindquist S; Whitehead Institute for Biomedical Research, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Stevens B; Harvard Medical School, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA; Boston Children's Hospital, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Stefanova N; Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Wenning G; Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., van de Berg WDJ; Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, the Netherlands., Luk KC; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Sanchez-Pernaute R; BioBizkaia Health Research Institute, Barakaldo, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain., Gómez-Esteban JC; BioBizkaia Health Research Institute, Barakaldo, Spain., Felsky D; Centre for Addiction and Mental Health, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada., Kiyota Y; Nikon Corporation, Tokyo, Japan., Sahni N; The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Baylor College of Medicine, Houston, TX, USA., Yi SS; The University of Texas at Austin, Austin, TX, USA., Chung CY; Yumanity Therapeutics, Cambridge, MA, USA., Stahlberg H; École Polytechnique Fédérale de Lausanne and University of Lausanne, Lausanne, Switzerland., Ferrer I; The University of Barcelona, Institut d'Investigacio Biomedica de Bellvitge IDIBELL, Hospitalet de Llobregat, Barcelona, Spain., Schöneberg J; University of California, San Diego, San Diego, CA, USA., Elledge SJ; Harvard Medical School, Boston, MA, USA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Dettmer U; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Halliday GM; The University of Sydney Brain and Mind Centre and Faculty of Medicine and Health School of Medical Science, Sydney, NSW, Australia; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA., Bartels T; Dementia Research Institute, University College London, London, UK., Khurana V; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Division of Movement Disorders, American Parkinson Disease Association (APDA) Center for Advanced Research and MSA Center of Excellence, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA; Harvard Stem Cell Institute, Cambridge, MA, USA. Electronic address: khuranalab_admin@bwh.harvard.edu.

Publikováno v: Neuron [Neuron] 2024 Sep 04; Vol. 112 (17), pp. 2886-2909.e16. Date of Electronic Publication: 2024 Jul 29.